天津医药2024,Vol.52Issue(8) :888-892.DOI:10.11958/20231637

放射性心脏损伤相关信号通路及药物干预的研究进展

Research progress on signaling pathways and drug intervention in radiation-induced heart disease

黄愿 王刚 李燕玲 谢萍
天津医药2024,Vol.52Issue(8) :888-892.DOI:10.11958/20231637

放射性心脏损伤相关信号通路及药物干预的研究进展

Research progress on signaling pathways and drug intervention in radiation-induced heart disease

黄愿 1王刚 2李燕玲 3谢萍3
扫码查看

作者信息

  • 1. 甘肃中医药大学第一临床医学院(邮编 730000)
  • 2. 兰州大学第一临床医学院
  • 3. 甘肃省人民医院心内一科
  • 折叠

摘要

放射性心脏损伤(RIHD)是继发于胸部肿瘤放疗后的心脏毒性事件,已成为除癌细胞毒性外,影响癌症患者机体健康的又一不利因素.信号传导在细胞信息交流中发挥重要作用,RIHD可诱导信号通路失调,阻碍通路功能的正常发挥,从而引起心肌组织发生凋亡、氧化应激及纤维化等病变.现综述RIHD发生发展中失调的相关通路,以及药物干预对通路的调控作用,为防治RIHD提供参考依据.

Abstract

Radiation-induced heart disease(RIHD)is a cardiotoxic event secondary to radiotherapy for thoracic tumors,and has become another unfavorable factor affecting the health of cancer patients in addition to cancer cytotoxicity.Signal transduction plays an important role in cellular information exchange.RIHD can induce dysregulation of signaling pathways and hinder the normal function of pathways,thus causing myocardial tissue to undergo lesions such as apoptosis,oxidative stress and fibrosis.Now,we review the relevant pathways that are dysregulated in the development of RIHD,as well as the regulatory effects of drug intervention on these pathways,in order to provide a reference basis for the prevention and treatment of RIHD.

关键词

化放疗/肿瘤/放射性心脏损伤/信号通路/药物干预

Key words

chemoradiotherapy/tumor/radiation-induced heart disease/signaling pathways/pharmacological interventions

引用本文复制引用

基金项目

甘肃省自然科学基金项目(22JR5RA665)

甘肃省自然科学基金项目(23JRRA1287)

甘肃省自然科学基金项目(23JRRA1315)

甘肃省科技计划项目(20YF3WA011)

兰州市人才创新创业项目(2018-RC-72)

出版年

2024
天津医药
天津市医学科学技术信息研究所

天津医药

CSTPCD
影响因子:1.107
ISSN:0253-9896
段落导航相关论文